Cargando…
Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?
Greaves discusses a new study in PLoS Medicine that takes us closer to being able to adopt a pharmacogenetic approach to reduce bleeding risk from coumarin therapy.
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1261512/ https://www.ncbi.nlm.nih.gov/pubmed/16231978 http://dx.doi.org/10.1371/journal.pmed.0020342 |
| _version_ | 1782125872028844032 |
|---|---|
| author | Greaves, Mike |
| author_facet | Greaves, Mike |
| author_sort | Greaves, Mike |
| collection | PubMed |
| description | Greaves discusses a new study in PLoS Medicine that takes us closer to being able to adopt a pharmacogenetic approach to reduce bleeding risk from coumarin therapy. |
| format | Text |
| id | pubmed-1261512 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-12615122005-10-25 Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? Greaves, Mike PLoS Med Perspectives Greaves discusses a new study in PLoS Medicine that takes us closer to being able to adopt a pharmacogenetic approach to reduce bleeding risk from coumarin therapy. Public Library of Science 2005-10 2005-10-25 /pmc/articles/PMC1261512/ /pubmed/16231978 http://dx.doi.org/10.1371/journal.pmed.0020342 Text en Copyright: © 2005 Mike Greaves. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Perspectives Greaves, Mike Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title | Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title_full | Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title_fullStr | Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title_full_unstemmed | Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title_short | Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion? |
| title_sort | pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion? |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1261512/ https://www.ncbi.nlm.nih.gov/pubmed/16231978 http://dx.doi.org/10.1371/journal.pmed.0020342 |
| work_keys_str_mv | AT greavesmike pharmacogeneticsinthemanagementofcoumarinanticoagulanttherapythewayforwardoranexpensivediversion |